Press Releases
Recro Pharma Receives Complete Response Letter from the FDA
Recro Pharma Reports First Quarter 2018 Financial Results
Recro Pharma Announces Receipt of Issue Notifications for Three New Patents for IV Meloxicam
Recro Pharma Announces Commercial Team Additions
Recro Pharma to Report First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 9, 2018
Recro Pharma Presents Data for Neuromuscular Blocking and Reversal Agents at the AUA 2018 Annual Meeting
Recro Pharma to Present IV Meloxicam Data at the 43rd Annual Regional Anesthesiology and Acute Pain Medicine Meeting
Recro Pharma Announces Commercial Team Additions
Recro Pharma Announces Publication of Phase III IV Meloxicam Bunionectomy Data in the Clinical Journal of Pain
